Mary S. Bradley

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer et al. · Journal of Investigative Dermatology · 2014 · 460 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +11

Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab

Aidan A. Long, Abdelkader Rahmaoui, Kenneth J. Rothman et al. · Journal of Allergy and Clinical Immunology · 2014 · 222 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma

Carlos Iribarren, Abdelkader Rahmaoui, Aidan A. Long et al. · Journal of Allergy and Clinical Immunology · 2016 · 115 citations

Medicine, Pharmacology, Pharmacotherapy +17

A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

Jeffrey M. Harris, Romeo Maciuca, Mary S. Bradley et al. · Respiratory Research · 2016 · 99 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Baseline characteristics of patients enrolled in EXCELS: a cohort study

Aidan A. Long, James E. Fish, Abdelkader Rahmaoui et al. · Annals of Allergy Asthma & Immunology · 2009 · 51 citations

Public Health, Biostatistics, Health Sciences +9